Importance of pretreatment viral load and monitoring of serum hepatitis C virus RNA in predicting responses to interferon-α2a treatment of chronic hepatitis C

Journal of Interferon and Cytokine Research

Volumn 17, Issue 11, 1997, Pages 707-712

  Wada, Masaaki ^a   Kang, Kyong Boo ^b   Nishigami, Takashi ^a   Shimoyama, Takashi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KOBE ASAHI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; HEPATITIS C; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA ANALYSIS; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS GENE;

HEPATITIS C VIRUS;

EID: 0030679690     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.707     Document Type: Article

References (28)

1. HOOFNAGLE, J.H., MULLEN, K.D., JONES, D.B., RUSTGI, V., DIBISCEGLIE, A., PETERS, M., WAGGONER, J.G., PARK, Y., and JONES, E.A. (1986). Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N. Engl. J. Med. 315, 1575-1578.
2. DAVIS, G.L., BALART, L.A., SCHIFF, E.R., LINDSAY, K., BODENHEIMER, H.C., PERRILLO, R.P., CAREY, W., JACOBSON, I.M., PAYNE, J., DIENSTAG, J.L., VAN THIEL, D.H., TAMBURRO, C., LEFKOWITCH, J., ALBRECHT, J., MESCHIEVITZ, C., ORTEGO, T.J., GIBAS, A., and THE HEPATITIS INTERVENTIONAL THERAPY GROUP. (1989). Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N. Engl. J. Med. 321, 1501-1506.
3. CAUSSE, X., GODINOT, H., CHEVALLIER, M., CHOSSEGROS, P., ZOULIM, F., OUZAN, D., HEYRAUD, J.-P., FONTANGES, T., ALBRECHT, J., MESCHIEVITZ, C., and TREPO, C. (1991). Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101, 497-502.
4. MARCELLIN, P., BOYER, N., GIOSTRA, E., DEGOTT, C., COUROUCE, A.M., DEGOS, F., COPPERE, H., CALES, P., COUZIGOU, P., and BENHAMOU, J.-P. (1991). Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 13, 393-397.
5. HAGIWARA, H., HAYASHI, N., MITA, E., UEDA, K., TAKEHARA, T., KASAHARA, A., FUSAMOTO, H., and KAMADA, T. (1992). Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 15, 37-41.
6. TINE, F., MAGRIN, S., CRAXI, A., and PAGLIARO, L. (1991). Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J. Hepatol. 13, 192-199.
7. HAGIWARA, H., HAYASHI, N., KASAHARA, A., OSHITA, M., KATAYAMA, K., NAITO, M., MASUZAWA, M., YOSHIHARA, H., SHIMIZU, Y., FUSAMOTO, H., and KAMADA, T. (1996). Long-term biochemical and virological response to natural interferon-α in patients with chronic hepatitis C. Dig. Dis. Sci. 41, 1001-1007.
8. ARASE, Y., KUMADA, H., CHAYAMA, K., TSUBOTA, A., KOIDA, I., IKEDA, K., SAITOH, S. MATSUMOTO, T., and KOBAYASHI, M. (1994). Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C. J. Gastroenterol. 29, 299-304.
9. TOYODA, H., NAKANO, S., TAKEDA, I., KUMADA, T., SUGIYAMA, K., OSADA, T., KIRIYAMA, S., SUGA, T., OHKI, H., ITO, O., EBATA, M., and TAKAHASHI, M. (1994). Retreatment of chronic hepatitis C with interferon. Am. J. Gastroenterol. 89, 1453-1457.
10. RABINOVITZ, M., BLOCK, G., and FINKELSTEIN, S.D. (1996). α-Interferon retreatment of patients with chronic hepatitis C. Am. J. Gastroenterol. 91, 1523-1526.
11. NIEDERAU, C, HEINTGES, T., and HÄUSSINGER, D. (1996). Treatment of chronic hepatitis C with α-interferon: an analysis of the literature. Hepatogastroenterology 43, 1544-1556.
12. LIN, R., LIDDLE, C., BYTH, K., and FARRELL, G.C. (1996). Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J. Viral Hepatitis 3, 85-96.
13. YOSHIOKA, K., KAKUMU, S., WAKITA, T., ISHIKAWA, T. ITOH, Y., TAKAYANAGI, M., HIGASHI, Y., SHIBATA, M., and MORISHIMA, T. (1992). Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 16, 293-299.
14. TSUBOTA, A., CHAYAMA, K., IKEDA, K., YASUJI, A., KOIDA, I., SAITOH, S., HASHIMOTO, M., IWASAKI, S., KOBAYASHI, M., and KUMADA, H. (1994). Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19, 1088-1094.
15. YAMADA, G., TAKATANI, M., KISHI, R, TAKAHASHI, M., DOI, T., TSUJI, T., SHIN, S., TANNO, M., URDEA, M.S., and KOLBERG, J.A. (1995). Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22, 1351-1354.
16. PICCIOTTO, A., CAMPO, N., BRIZZOLARA, R., SINELLI, N., POGGI, G., GRASSO, S., and CELLE, G. (1997). HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy. Eur. J. Gastroenterol. Hepatol. 9, 67-69.
17. OKAMOTO, H., OKADA, S., SUGIYAMA, Y., TANAKA, T., SUGAI, Y., AKAHANE, Y., MACHIDA, A., MISHIRO, S., YOSHIZAWA, H., MIYAKAWA, Y., and MAYUMI, M. (1990). Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn. J. Exp. Med. 60, 215-222.
18. CHAYAMA, K., TSUBOTA, A., ARASE, Y., SAITOH, S., IKEDA, K., SAKAI, Y., MATSUMOTO, T., KOBAYASHI, M., UNAKAMI, M., MORINAGA, T., and KUMADA, H. (1993). Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction. J. Gastroenterol. Hepatol. 8, S40-44.
19. CHAYAMA, K., TSUBOTA, A., ARASE, Y., SAITOH, S., KOIDA, I., IKEDA, K., MATSUMOTO, T., KOBAYASHI, M., IWASAKI, S., KOYAMA, S., MORINAGA, T., and KUMADA, H. (1993). Genotypic subtyping of hepatitis C virus. J. Gastroenterol. Hepatol. 8, 150-156.
20. ISHAK, K., BAPTISTA, A., BIANCHI, L., CALLEA, F., DE GROOTE, J., GUDAT, F., DENK, H., DESMET, V., KORB, G., MACSWEEN, R.N.M., PHILLIPS, M.J., PORTMANN, B.G., POULSEN, H., SCHEUER, P.J., SCHMID, M., and THALER, H. (1995). Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696-699.
21. CHEMELLO, L., CAVALLETTO, L., CASARIN, C., BONETTI, P., BERNARDINELLO, E., PONTISSO, P., DONADA, C., BELUSSI, F., MARTINELLI, S., ALBERTI, A., and THE TRIVENETO VIRAL HEPATITIS GROUP. (1996). Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C. Ann. Intern. Med. 124, 1058-1060.
22. CRAXÌ, A., ALMASIO, P., and SCHALM, S. (on behalf of EUROHEP). (1996). Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP consensus report on response criteria. J. Viral Hepatitis 3, 273-276.
23. GRETCH, D.R., ROSA, C.D., COREY, L., and CARITHERS, R.L. (1996). Assessment of hepatitis C viremia using molecular amplification technologies. Viral Hepatitis Rev. 2, 85-96.
24. KLETER, G.E.M., BROUWER, J.T., HEIJTINK, R.A., SCHALM, S.W., and QUINT, W.G.V. (1993). Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon. Antimicrob. Agents Chemother. 37, 595-597.
25. ORITO, E., MIZOKAMI, M., SUZUKI, K., OHBA, K., OHNO, T., MORI, M., HAYASHI, K., KATO, K., IINO, S., and LAU, J.Y.N. (1995). Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J. Med. Virol. 46, 109-115.
26. AMPURDANÉS, S., OLMEDO, E., MALUENDA, M.D., FORNS, X., LÓPEZ-LABRADOR, EX., COSTA, J., SÁNCHEZ-TAPIAS, J.M., JIMENEZ DE ANTA, M.T., and RODÉS J. (1996). Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. J. Hepatol. 25, 827-832.
27. HINO, K., OKUDA, M., KONISHI, T., ISHIKO, H., and OKITA, K. (1995). Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig. Dis. Sci. 40, 14-20.
28. KARINO, Y., TOYOTA, J., SUGAWARA, M., HIGASHINO, K., SATO, T., OHMURA, T., SUGA, T., OKUUCHI, Y., and MATSUSHIMA, T. (1997). Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am. J. Gastroenterol. 92, 61-65.